Curis to Release Fourth Quarter and Year End 2012 Financial Results and Hold Conference Call on February 20, 2013

[at noodls] – LEXINGTON, Mass., Feb. 13, 2013 (GLOBE NEWSWIRE) — Curis, Inc. (Nasdaq:CRIS), a drug development company seeking to develop proprietary targeted medicines for cancer treatment, today announced that the … more

View todays social media effects on CRIS

View the latest stocks trending across Twitter. Click to view dashboard

See who Curis is hiring next, click here to view